To Summarize: Markets are entering a “risk on” phase to start the year, with small caps, emerging markets, and biotech leading gains. Commodities and high-yield credit are climbing, fueled by narrow credit spreads and stronger risk tolerance by investors. Growth expectations for 2026 are rising, supported by anticipated rate cuts by the Federal Reserve (Fed) and fiscal stimulus from upcoming tax law changes. Economic activity is firming, as seen in accelerating small and mid-cap earnings and increased bank lending.
The big takeaway – Investors are embracing risk, driving new leadership and optimism across markets.
In the Markets: The markets kicked off 2026 with a dynamic rally, as smaller company stocks and emerging markets surge ahead, outshining even the S&P 500 and Nasdaq. High-yield bonds and global commodities are rising on expectations of robust growth this year. Speculative biotech stocks continue to outperform, while bond investors accept the lowest spreads in decades, signaling strong confidence across asset classes despite Bitcoin remaining flat.
Rate Cut Expectations Drive Optimism: Investors’ appetite for risk is surging as markets anticipate two interest rate cuts from the Fed — one in the summer and another by year-end under the new chairman. The prospect of easier monetary policy is fueling positive momentum in stocks and bonds, with lower rates expected to reduce borrowing costs and lift asset prices. This climate is encouraging investors to seek higher returns across both markets.
GDP Growth Driving Economic Acceleration: Recent GDPNow date highlights a renewed boost in economic activity following a brief slowdown. With 2025 tax law changes expected to lift GDP by nearly a full percentage point, optimism is rising. Accelerating earnings growth, increased bank lending, and a boom in capital markets are fueling a strong outlook and setting the stage for strong market momentum.
Top Headlines: We’re reading about the quiet risk that could slow AI growth, the AI lab to accelerate drug discovery by Nvidia and Lilly, how home sellers are outnumbering buyers by a record margin, and how Medicare Advantage rates are impacting health insurers.
Related resources:
- AI: The quiet risk that could slow the growth of AI
- Health Tech: Nvidia and Lilly announce co-innovation AI lab to accelerate drug discovery
- Real Estate: Home sellers outnumber buyers by a record margin, upper buyers’ bargaining power
- Healthcare: How Medicare Advantage rates are impacting health insurers
Disclosures
Investment advisory services are offered by Aprio Wealth Management, LLC, a Securities and Exchange Commission Registered Investment Advisor. Opinions expressed are as of the publication date and subject to change without notice. Aprio Wealth Management, LLC shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, the information, data, analyses or opinions contained herein or their use, which do not constitute investment advice, are provided as of the date written, are provided solely for informational purposes and therefore are not an offer to buy or sell a security. This commentary is for informational purposes only and has not been tailored to suit any individual. References to specific securities or investment options should not be considered an offer to purchase or sell that specific investment.
This commentary contains certain forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially and/or substantially from any future results, performance or achievements expressed or implied by those projected in the forward-looking statements for any reason. No graph, chart, or formula in this presentation can be used in and of itself to determine which securities to buy or sell, when to buy or sell securities, whether to invest using this investment strategy, or whether to engage Aprio Wealth Management, LLC’s investment advisory services.
Investments in securities are subject to investment risk, including possible loss of principal. Prices of securities may fluctuate from time to time and may even become valueless. Any securities mentioned in this commentary are not FDIC-insured, may lose value, and are not guaranteed by a bank or other financial institution. Before making any investment decision, investors should read and consider all the relevant investment product information. Investors should seriously consider if the investment is suitable for them by referencing their own financial position, investment objectives, and risk profile before making any investment decision. There can be no assurance that any financial strategy will be successful.
Certain investor qualifications may apply. Definitions for Qualified Purchaser, Qualified Client and Accredited Investor can be found from multiple sources online or in the SEC’s glossary found here https://www.sec.gov/education/glossary/jargon-z#Q